Search

everythinglearnresearchcommunity

for

Search:↓

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

ECM changes may play a role in hair loss, with differences between males and females.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Exosomes may help stimulate hair growth and improve hair loss conditions like androgenic alopecia.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

TNF-a may not be as involved in certain types of hair loss as previously thought.

New treatment with Wnt proteins and growth factors safely increases hair thickness.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Low PON1 levels may indicate and predict the severity of hair loss.

Changes in NRF2 levels may contribute to hair loss in Egyptian men.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Stem cell therapies show promise for hair regrowth but face production and application challenges.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Sex-determining genes may affect male baldness.

Increased PPARGC1α relates to hair thinning in common baldness.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.